Alveo Technologies
Dr. Slava Elagin brings to Alveo more than 20 years of experience in the in vitro diagnostics and medical devices industry. Previously, Slava held senior executive operations and research and development positions with publicly traded and private companies including MiraVista Diagnostics, Meridian Biosciences, EraGen Biosciences, and Third Wave Technologies. He has led 15 molecular diagnostic product development projects from product concept through U.S. Food & Drug Administration clearances and commercialization and is the author on 12 U.S. patents and three global patents for molecular assays and diagnostics.
This person is not in any offices
Alveo Technologies
1 followers
Alveo is leading the transformation of the consumer health tech market by developing a low-cost, easy- to-use, at-home diagnostic platform that has the potential to change the way infectious diseases are detected and managed.